1. Australia Stocks

  2. •

    Health technology

  3. •

    Biotechnology
Curvebeam AI Ltd.

Curvebeam AI Ltd.

AASX:CVB
0.02
AUD
+0.00
(+5.00%)
-0.08EPS
50.84MMarket Cap
Mar 04Next Earn
Curvebeam AI Ltd.
ASX:CVB
(Australian Securities Exchange)

Recent

price

0.02

P/E

ratio

- -

div

yld

- -

ROIC.AI

1999
2000
2001
2002
2003
2004
2005
2006
2007
2008
2009
2021
2022
2023
2024
2025
AUD
- -
- -
- -
- -
0.01
0.01
0.2
0.26
0.35
0.29
0.3
0.02
0.02
0.13
0.02
- -
Revenue per Share
- -
-0.29
-0.13
-0.09
-0.08
-0.02
0.03
- -
0.01
-0.05
0.01
-0.02
-0.03
-0.85
-0.08
- -
Basic EPS, GAAP
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow per Basic Share
- -
- -
- -
0.09
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
0.49
0.32
0.2
0.02
0.09
0.22
0.3
0.29
0.29
0.23
0.23
- -
- -
-0.69
0.12
- -
Book Value per Share
0.49
0.29
0.17
0.02
0.09
0.22
0.02
-0.05
-0.02
- -
- -
- -
- -
-1.28
- -
- -
Tangible Book Value per Share
50
30
50
50
5
9
47
77
85
99
100
331
331
60
294
375
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
9
20
30
29
30
7
7
8
7
- -
Sales/Revenue/Turnover
- -
- -
-7,294.74
-2,074.04
-841.97
-420.44
-0.19
1.75
2.55
0.1
4.27
-105.92
-161.61
-232.85
-366.76
- -
Operating Margin (%)
- -
- -
1
- -
- -
- -
1
- -
1
- -
- -
- -
- -
2
3
- -
Depreciation Expense
- -
-9
-6
-4
- -
- -
2
- -
1
-5
1
-7
-10
-51
-23
- -
Net Income, GAAP
- -
- -
- -
- -
- -
- -
100
28.03
8.57
- -
14.92
- -
- -
- -
- -
- -
Effective Tax Rate (%)
- -
- -
-6,631.58
-3,481.15
-780.27
-338.18
16.43
1.81
3.13
-16.55
3.23
-93.73
-129.66
-635.95
-353.94
- -
Profit Margin (%)
22
14
8
1
- -
2
3
-1
1
4
4
- -
- -
-19
15
- -
Working Capital
- -
- -
- -
- -
- -
- -
2
4
5
6
6
- -
- -
13
15
- -
LT Debt
25
16
10
1
- -
2
23
24
26
23
23
- -
- -
-48
39
- -
Total Equity
- -
- -
- -
- -
- -
- -
- -
0.89
2.2
- -
3.38
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
10.9
2.34
4.7
- -
5.07
- -
- -
- -
- -
- -
Return on Capital (%)
- -
-43.13
-48.35
-83.12
-58.96
-17.54
12.5
1.56
3.75
-19.93
4.28
-58.56
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

AUD

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

AUD

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
- -
- -
Free Cash Flow
- -
- -
- -
Net Income, GAAP
- -
- -
- -
Sales/Revenue/Turnover
- -
- -
- -
Total Cash Common Dividend
- -
- -
- -

Semi-annual Revenue

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
8
2024
- -
- -
7
2025
- -
- -
- -

Semi-annual Earnings Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
-0.85
2024
- -
- -
-0.08
2025
- -
- -
- -

Semi-annual Dividends Per Share

AUD

•

in mil. unless spec.

Year

H1
H2
FY
2023
- -
- -
- -
2024
- -
- -
- -
2025
- -
- -
- -
Similar Companies
Moderna, Inc. (NASDAQ:MRNA)
Amgen Inc. (NASDAQ:AMGN)
Iovance Biotherapeutics, Inc. (NASDAQ:IOVA)
Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX)
Novavax, Inc. (NASDAQ:NVAX)
10x Genomics, Inc. (NASDAQ:TXG)
Business
CurveBeam AI Ltd. engages in the research, design, and manufacture of cone beam computed tomography imaging systems. It operates through the following geographical segments: North America, Europe, and Rest of World. The company was founded in September 2022 and is headquartered in Melbourne, Australia.